The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sangamo Therapeutics Inc

Nasdaq: SGMO
Last

(U.S.) $13.75

Today's change0.00 0.00%
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sangamo Therapeutics Inc

Nasdaq: SGMO
Last

(U.S.) $13.75

Today's change0.00 0.00%
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.

Sangamo Therapeutics Inc closed at (U.S.)$13.75.

Shares have lost 2.83% over the last five days, but have gained 350.82% over the last year to date. This security has outperformed the S&P 500 by 170.34% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $13.75
  • High--
  • Low--
  • Bid / Ask(U.S.) $13.20 / (U.S.) $14.40
  • YTD % change+350.82%
  • Volume0
  • Average volume (10-day)1,760,347
  • Average volume (1-month)2,019,826
  • Average volume (3-month)1,524,059
  • 52-week range(U.S.) $2.65 to (U.S.) $15.05
  • Beta3.13
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.81
Updated September 22 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue8393
Total other revenue--------
Total revenue8393
Gross profit--------
Total cost of revenue--------
Total operating expense21201922
Selling / general / administrative6755
Research & development15131417
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-13-17-10-19
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-12-17-10-19
Income after tax-12-17-10-19
Income tax, total0--00
Net income-12-17-10-19
Total adjustments to net income--------
Net income before extra. items-12-17-10-19
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-12-17-10-19
Inc. avail. to common incl. extra. items-12-17-10-19
Diluted net income-12-17-10-19
Dilution adjustment--------
Diluted weighted average shares73717171
Diluted EPS excluding extraordinary itemsvalue per share-0.17-0.23-0.14-0.27
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.17-0.23-0.14-0.27